Drotaverine Hydrochloride Injection 40?mg (No?Spa )

Drotaverine Hydrochloride Injection 40?mg (No?Spa )

(1 customer review)

$1.00

No?Spa Drotaverine Hydrochloride Injection delivers 40?mg per 2?ml ampoule, with five ampoules per box. Produced by CHINOIN (Hungary) and approved under NMPA HJ20170302. Ideal for laboratory research involving smooth muscle spasm relief in visceral organs and vascular systems.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Drotaverine is a benzylisoquinoline antispasmodic that selectively inhibits phosphodiesterase-4 (PDE4), resulting in increased cAMP and smooth muscle relaxation in the gastrointestinal tract, bile ducts, urinary system, and blood vessels. With its rapid onset of action and vasodilatory effects, it’s widely used in laboratory research for studying colic relief, biliary spasm, uterine relaxation, and vascular smooth muscle modulation.


Drotaverine Hydrochloride Injection Product Specifications

ParameterDetails
Product NameDrotaverine Hydrochloride Injection (No?Spa / ???)
Active IngredientDrotaverine Hydrochloride
CAS Number14009?24?6
Chemical FormulaC??H??NO?
Molecular Weight~397.5?g/mol
FormulationAqueous solution for injection, ampoule format
Strength per Ampoule40?mg in 2?ml
Pack Size5 ampoules per box
Dosage FormInjectable solution
Approval No.HJ20170302
Drug Code86982100000015
ManufacturerCHINOIN Pharmaceutical and Chemical Works (Hungary)
Barcode6950641900174
Storage ConditionsStore at 20–25?°C in a dry, dark place
Intended UseLaboratory research on colic, smooth muscle spasm, vascular modulation

Drotaverine Hydrochloride Injection Mechanism of Action

Drotaverine selectively inhibits PDE4, increasing cellular cAMP levels and activating PKA, which leads to myosin light chain kinase (MLCK) inhibition for smooth muscle relaxation. It also exhibits calcium-channel blocking effects, enhancing its antispasmodic and vasodilatory actions.


Research Applications

  • Gastro?intestinal colic: e.g., gallstones, gastritis, IBS

  • Ureteric and renal colic relief

  • Biliary tract spasms: cholecystitis, biliary colic

  • Gynecological spasms: dysmenorrhea, uterine contractions

  • Vascular smooth muscle relaxation and hemodynamic studies


Safety & Handling

  • Dosage & Use: In animal models, typically 40–80?mg slow IV or IM injection, 1–3 times daily .

  • Side Effects: Headache, dizziness, nausea; rare arrhythmia, hypotension, hypersensitivity.

  • Contraindications: Known allergy to drotaverine or sulfite preservatives, severe liver/kidney/heart failure.

  • Handling: Use standard lab PPE; avoid needle-stick and aerosol exposure.

  • Storage: Maintain at 20–25?°C, shield from light/moisture.


Core Keywords

drotaverine injection, No?Spa ampoule, 40mg drotaverine, CAS 14009?24?6, PDE?4 inhibitor smooth muscle relaxant, HJ20170302, antispasmodic injection, biliary spasm research, wholesale drotaverine


Research Use Disclaimer

This product is strictly for laboratory and research use. Not approved for therapeutic, diagnostic, clinical, or veterinary applications. Misuse may lead to legal or health consequences. Use only under approved institutional protocols.

Additional information

Weight1 kg
Dimensions26 × 32 × 26 cm

1 review for Drotaverine Hydrochloride Injection 40?mg (No?Spa )

  1. pesi

    La consegna ha richiesto un po’ di tempo, tutto il resto è andato bene, grazie

Add a review

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare